Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

EVITRADE Announces AGSM Results and Broker-Dealer Selected as Financial Advisor

C.TMED

EVITRADE Announces AGSM Results and Broker-Dealer Selected as Financial Advisor


Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp. (CSE:EVA, OTCQB: AXHLF) (the “Company”) announces that at the Annual General and Special Meeting all resolutions were approved unanimously.  In addition, under advisement from our newly elected board member, Mr. CK Cheung, (an Executive Director with the China Investment Trust), the board is pleased to announce that a licensed broker-dealer in Canada and USA, has been selected as a financial advisor to the Company. This broker-dealer has participated in multiple bought deal financings and have listed and up-listed companies in numerous sectors.  Management believes that the divestiture of the C&C subsidiary will benefit from the broker-dealer’s involvement and management believes there will be a good fit for working with our remaining subsidiaries, including our main digital healthcare company.  Details are to be released upon receiving appropriate clearances.

For the Industrial Hemp and Cannabis Farm, CBD Plant Oils Extraction Company and the C&C subsidiary merger (to be finalized under comprehensive definitive agreement(s)); it is expected that all shareholders holding shares on the share record distribution date for that subsidiary, will receive shares on a 1:1 basis with no consolidation.  Under the approved plan of arrangement each subsidiary can have different share distribution ratios of up to a 20:1 consolidation effect, different share record distribution dates, and different effective dates; all which shall be announced in the near future.

Contact: Ron Ozols, Director

EVITRADE Health Systems Corporation

(formerly Auxellence Health Corporation)

Twitter: @evitradehealth or https://twitter.com/evitradehealth

Email: info@auxellence.com

Website: http://www.auxellence.com

CSE Micro-site: http://thecse.com/en/listings/technology/evitrade-health-systems-corp

US OTC Markets: http://www.otcmarkets.com/stock/AXHLF/news

About EVITRADE Health (CSE: EVA, OTCQB: AXHLF)

EVITRADE (formerly Auxellence Health Corp.), was founded in 2013 to provide online “digital healthcare” services for resolving common health problems. The current markets are weight-loss, high blood pressure, high blood glucose and heart arrhythmia.

 

Disclaimers – Forward Looking Statements

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators and on the OTC Markets website which is posted on www.sedar.com, http://thecse.com/en/listings/technology/evitrade-health-systems-corp, and http://www.otcmarkets.com/stock/AXHLF/filings. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.


To view this press release as a PDF file, click onto the following link:
public://news_release_pdf/evitrade03062017_0.pdf
Source: EVITRADE Health Systems Corp. (CSE:EVA, OTCQB:AXHLF)

To follow EVITRADE Health Systems Corp. on your favorite social media platform or financial websites, please click on the icons below.


Maximum News Dissemination by FSCwire. http://www.fscwire.com

Copyright © 2017 Filing Services Canada Inc.